Influence of physical activity on active surveillance discontinuation in men with low-risk prostate cancer

被引:0
|
作者
Efthymios Papadopoulos
Shabbir M. H. Alibhai
George A. Tomlinson
Andrew G. Matthew
Michael Nesbitt
Antonio Finelli
John Trachtenberg
Daniel Santa Mina
机构
[1] University of Toronto,Faculty of Kinesiology and Physical Education
[2] Princess Margaret Cancer Centre,Department of Supportive Care
[3] University of Toronto,Faculty of Medicine
[4] University Health Network,Department of Medicine
[5] Princess Margaret Cancer Centre,Division of Urology, Department of Surgical Oncology
[6] University of Toronto,Institute for Health Policy, Management, and Evaluation
来源
Cancer Causes & Control | 2019年 / 30卷
关键词
Prostate cancer; Low-risk disease; Active surveillance; Physical activity; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1009 / 1012
页数:3
相关论文
共 50 条
  • [41] THE ERA OF ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER IS HERE
    Sountoulides, Petros
    Obek, Can
    ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (02): : 49 - 51
  • [42] Super active surveillance for low-risk prostate cancer | Opinion: No
    Ghodoussipour, Saum
    Lebastchi, Amir
    Pinto, Peter
    Berger, Andre
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 215 - 219
  • [43] Active Surveillance for Low-risk Prostate Cancer: Will it Become Obsolete?
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2019, 75 (05) : 750 - 751
  • [44] Active surveillance beats surgery in low-risk prostate cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [45] Active Surveillance for Low-risk Prostate Cancer: Developments to Date
    Bangma, Chris H.
    Valdagni, Riccardo
    Carroll, Peter R.
    van Poppel, Hein
    Klotz, Laurence
    Hugosson, Jonas
    EUROPEAN UROLOGY, 2015, 67 (04) : 646 - 648
  • [46] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [47] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [48] Contemporary Use of Initial Active Surveillance Among Men in Michigan with Low-risk Prostate Cancer
    Womble, Paul R.
    Montie, James E.
    Ye, Zaojun
    Linsell, Susan M.
    Lane, Brian R.
    Miller, David C.
    EUROPEAN UROLOGY, 2015, 67 (01) : 44 - 50
  • [49] Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance
    Lin, Daniel W.
    Crawford, E. David
    Keane, Thomas
    Evans, Brent
    Reid, Julia
    Rajamani, Saradha
    Brown, Krystal
    Gutin, Alexander
    Tward, Jonathan
    Scardino, Peter
    Brawer, Michael
    Stone, Steven
    Cuzick, Jack
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (06) : 310.e7 - 310.e13
  • [50] Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer
    Sathianathen, Niranjan J.
    Konety, Badrinath R.
    Alarid-Escudero, Fernando
    Lawrentschuk, Nathan
    Bolton, Damien M.
    Kuntz, Karen M.
    EUROPEAN UROLOGY, 2019, 75 (06) : 910 - 917